Common Side Effects Injection site redness or mild swelling
their assistance is not a substitute for professional medical advice
WEIGHT-LOSS DOCTOR SHARES HOW GLP-1S COULD REWIRE BODY AGAINST DISEASE The study, published in JAMA Oncology, examined health record data from 2014 to 2024 for adults over 18 who were eligible for anti-obesity medications and did not have a prior cancer history
[DOI] [PMC free article] [PubMed] [Google Scholar] 133.Quast D.R., Nauck M.A., Schenker N., Menge B.A., Kapitza C., Meier J.J
The drug is not approved anywhere in the world
Tirzepatide and retatrutide supplement notes If you are using tirzepatide , we have a dedicated guide covering supplements to take with tirzepatide that addresses the specific dual GIP/GLP-1 receptor agonist considerations